Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jordan E. Lateiner
Observed names:
Jordan E Lateiner,
Jordan Lateiner,
Lateiner, Jordan E
Observed institutions:
AbbVie (United States),
Allergan (United States),
Forest Laboratories (United States)
OpenAlex ID:
A5080183574
Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies
2019
·
Antonio Y Hardan
, Robert L Hendren
, et al.
·
Autism
·
50
PDF
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials
2022
·
Richard B. Lipton
, Rashmi B. Halker Singh
, et al.
·
The Journal of Headache and Pain
·
17
PDF
Improved Functionality, Satisfaction, and Global Impression of Change With Ubrogepant for the Acute Treatment of Migraine in Triptan Insufficient Responders (1247)
2021
·
Jordan E. Lateiner
, Richard B. Lipton
, et al.
·
Neurology
·
2
ACCORD COPD I: Twice-daily aclidinium bromide improves quality of life and dyspnea in COPD patients
2011
·
Arthur Gelb
, James Donohue
, et al.
·
European Respiratory Journal
·
1
P4‐286: Characteristics of Alzheimer's disease patients switching from memantine hcl immediate‐release tablets to memantine hcl extended‐release tablets: A retrospective analysis of administrative claims
2015
·
Abhilasha Ramasamy
, Ron Aubert
, et al.
·
Alzheimer s & Dementia
P4‐285: Impact on outcomes of adding memantine to donepezil among patients with Alzheimer's disease
2015
·
Abhilasha Ramasamy
, Ron Aubert
, et al.
·
Alzheimer s & Dementia
PDF
Extended-Release Memantine for the Treatment of Autism Spectrum Disorder: Safety Data from 1004 Patients in a Phase II Clinical Development Program
2014
·
Jordan E. Lateiner
Memantine for the Treatment of Autism Spectrum Disorder: Overview of the Phase II Clinical Development Program (S42.009)
2014
·
Ephraim Katz
, Jordan Lateiner
, et al.
·
Neurology
Improvements In Quality Of Life And Dyspnea In COPD Patients With Twice-Daily Aclidinium
2011
·
Arthur F. Gelb
, James F. Donohue
, et al.
Show more works
View as search
Works count:
14
Citation count:
70
H-index:
2
I10-index:
2
Year
Topic
Type
